468 results on '"Ruozi, Barbara"'
Search Results
2. Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor
3. C-end rule peptide-guided niosomes for prostate cancer cell targeting
4. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
5. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology
6. Quantitative comparison of the protein corona of nanoparticles with different matrices
7. Challenges of enzyme therapy: Why two players are better than one.
8. Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease
9. Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence
10. Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
11. Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines
12. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery
13. “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury
14. Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]
15. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
16. Supplementary Table 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
17. Supplementary Figure 3 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
18. Supplementary Figure Legend from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
19. Supplementary Methods from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
20. Supplementary Figure 2 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
21. Supplementary Figure 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
22. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
23. Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides
24. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers
25. The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system
26. Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems
27. Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles
28. Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model
29. I17 Sustained benefits of brain-permeable cholesterol-loaded nanoparticles in zQ175DN mouse model
30. Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
31. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
32. Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
33. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release
34. Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
35. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution
36. Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders
37. PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury
38. Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles.
39. Tunneling Nanotubes: A New Target for Nanomedicine?
40. Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
41. Amphiphilic ion pairs of tobramycin with lipoamino acids
42. Tween® Preserves Enzyme Activity and Stability in PLGA Nanoparticles
43. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity
44. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter
45. Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations
46. Microfluidic Technology for the Production of Hybrid Nanomedicines
47. I07 A new generation of brain-targeted nanoparticles for cholesterol delivery in huntington’s disease: kinetics, drug release and behavioral effects in mouse models
48. Nanomedicines for brain diseases: where we are and where we are going
49. Microfluidic technology for the production of hybrid nanomedicines
50. Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.